Jaguar Health, Inc. | Business Contracts

Securities Purchase Agreement, dated September 13, 2021, by and between Jaguar Health, Inc. and the investors named therein (Filed With SEC on September 17, 2021)

License Agreement, dated August 18, 2021, by and between Napo Pharmaceuticals, Inc. and Napo EU S.p.A (Filed With SEC on August 24, 2021)

Certain information marked as [****] has been excluded from this exhibit because it is both (i)not material and (ii)would be competitively harmful if publicly disclosed.... (Filed With SEC on May 17, 2021)

CONSENT TO SUBLEASE AGREEMENT (Filed With SEC on May 17, 2021)

Royalty Interest, dated March 8, 2021, by and between Jaguar Health, Inc. and Streeterville Capital, LLC (Filed With SEC on March 11, 2021)

Form of Severance and Change of Control Agreement (Filed With SEC on August 13, 2020)

Subscription Agreement, dated June 1, 2021, by and among Dragon SPAC S.p.A., Napo Pharmaceuticals, Inc. and Joshua Mailman (Filed With SEC on June 4, 2021)

Certain information marked as [****] has been excluded from this exhibit because it is both (i)not material and (ii)would be competitively harmful if publicly disclosed. OFFICE... (Filed With SEC on May 17, 2021)

Form of Securities Purchase Agreement (Filed With SEC on April 30, 2021)

Placement Agency Agreement, dated April 29, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on April 30, 2021)

Office Lease Agreement, dated March 25, 2021, between Jaguar Health, Inc. and M & E, LLC (Filed With SEC on April 8, 2021)

Common Stock Purchase Warrant, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on April 8, 2021)

First Amendment to the Equity Purchase Agreement, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on April 8, 2021)

Registration Rights Agreement, dated April 7, 2021, between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on April 8, 2021)

Master Services Agreement, dated October 5, 2020, by and between Napo Pharmaceuticals, Inc. and Integrium, LLC (Filed With SEC on March 31, 2021)

Master Services Agreement, dated June 24, 2019, by and among Napo Pharmaceuticals, Inc., Integrium, LLC, and POC Capital, LLC (Filed With SEC on March 31, 2021)

Securities Purchase Agreement, dated March 8, 2021, by and between Jaguar Health, Inc. and Streeterville Capital, LLC (Filed With SEC on March 11, 2021)

Security Agreement, dated January 19, 2021, by and between Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC (Filed With SEC on January 22, 2021)

Note Purchase Agreement, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC (Filed With SEC on January 22, 2021)

Secured Promissory Note, dated January 19, 2021, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Streeterville Capital, LLC (Filed With SEC on January 22, 2021)

Form of Securities Purchase Agreement (Filed With SEC on January 14, 2021)

Placement Agency Agreement, dated January 13, 2021, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on January 14, 2021)

Securities Purchase Agreement, dated December 22, 2020, by and between Jaguar Health, Inc. and Irving Park Capital, LLC (Filed With SEC on December 29, 2020)

Royalty Interest, dated December 22, 2020, by and between Jaguar Health, Inc. and Irving Park Capital, LLC (Filed With SEC on December 29, 2020)

Consent to Sublease Agreement, dated August 31, 2020, by and among M&E, LLC, Jaguar Health, Inc., and Peacock Construction, Inc (Filed With SEC on November 16, 2020)

Office Sublease Agreement, dated August 31, 2020, by and between Jaguar Health, Inc. and Peacock Construction, Inc (Filed With SEC on November 16, 2020)

Manufacturing and Supply Agreement, dated September 3, 2020, by and between Glenmark Life Sciences Limited and Napo Pharmaceuticals, Inc (Filed With SEC on November 16, 2020)

Exchange Agreement, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on October 9, 2020)

Royalty Interest Purchase Agreement, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on October 9, 2020)

Royalty Interest, dated October 8, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on October 9, 2020)

Fee Settlement Agreement, dated October 7, 2020, by and between Jaguar Health, Inc. and Atlas Sciences, LLC (Filed With SEC on October 9, 2020)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on October 9, 2020)

Stock Plan Agreement, dated October 6, 2020, by and between Jaguar Health, Inc. and PoC Capital, LLC (Filed With SEC on October 7, 2020)

At The Market Offering Agreement, dated October 5, 2020, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on October 5, 2020)

Stock Plan Agreement for Payment of Consulting Services, dated September 1, 2020, by and among Jaguar Health, Inc., Sagard Capital Partners Management Corp. and Sagard Capital... (Filed With SEC on September 2, 2020)

Exchange Agreement, dated September 1, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on September 2, 2020)

Global Amendment, dated September 1, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P (Filed With SEC on September 2, 2020)

First Amendment to Purchase Agreement, dated June 26, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on August 13, 2020)

First Amendment to Assignment Agreement, dated June 26, 2020, by and between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on August 13, 2020)

First Amendment to Royalty Interest Purchase Agreement and Related Documents, dated July 10, 2020, between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on July 14, 2020)

Form of Notice of Grant of Restricted Stock Units and Restricted Stock Unit Agreement under the Jaguar Health, Inc. New Employee Inducement Award Plan (Filed With SEC on June 19, 2020)

Form of Notice of Grant of Stock Option and Stock Option Agreement under the Jaguar Health, Inc. New Employee Inducement Award Plan (Filed With SEC on June 19, 2020)

Jaguar Health, Inc. New Employee Inducement Award Plan (Filed With SEC on June 19, 2020)

Form of Inducement Letter for Bridge Warrants (Filed With SEC on May 22, 2020)

Form of Inducement Letter for Original Warrants (Filed With SEC on May 22, 2020)

Form of Series 3 Warrant (Filed With SEC on May 22, 2020)

Assignment Agreement, dated May 12, 2020, by and between Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on May 21, 2020)

Purchase Agreement, dated May 12, 2020, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Oasis Capital, LLC (Filed With SEC on May 21, 2020)

License Agreement, dated April 15, 2020, by and between Jaguar Health, Inc. and Atlas Sciences, LLC (Filed With SEC on April 16, 2020)

Purchase Agreement, dated April 15, 2020, by and between Napo Pharmaceuticals, Inc. and Atlas Sciences, LLC (Filed With SEC on April 16, 2020)

Description of the Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1945, as amended (Filed With SEC on April 3, 2020)

Jaguar Health, Inc. 2014 Stock Incentive Plan as Amended and Restated Effective October 1, 2019 (Filed With SEC on April 3, 2020)

Landlord Letter of Credit Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Charles Conte (Filed With SEC on March 26, 2020)

Equity Purchase Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on March 26, 2020)

Leak-Out Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and the Holder named therein (Filed With SEC on March 26, 2020)

Warrant Exercise and Preferred Stock Amendment Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and the Holder named therein (Filed With SEC on March 26, 2020)

Securities Purchase Agreement, dated March 23, 2020, by and between Jaguar Health, Inc. and the investors named therein (Filed With SEC on March 26, 2020)

Registration Rights Agreement, dated March 24, 2020, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on March 26, 2020)

Securities Purchase Agreement, dated March 4, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on March 6, 2020)

Royalty Interest, dated March 4, 2020, by and between Jaguar Health, Inc. and Iliad Research and Trading, L.P (Filed With SEC on March 6, 2020)

Form of Warrant Exercise Agreement by and between Jaguar Health, Inc. and the Holder named therein (Filed With SEC on February 28, 2020)

First Amendment to the Exchange Agreement, dated January 22, 2020, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on January 27, 2020)

Form of Warrant (Filed With SEC on December 26, 2019)

Lock-Up Agreement, dated December 23, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on December 26, 2019)

Exchange Agreement, dated December 23, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on December 26, 2019)

Securities Purchase Agreement, dated December 20, 2019, by and between Jaguar Health, Inc. and the investors named therein (Filed With SEC on December 26, 2019)

Securities Purchase Agreement, dated November 13, 2019, by and between Jaguar Health, Inc. and the purchasers named therein (Filed With SEC on November 14, 2019)

Form of Pre-Funded Common Stock Purchase Warrant (Filed With SEC on November 14, 2019)

China Life Science Advisory Agreement, dated October 8, 2019, by and between Jaguar Health, Inc. and Angel Pond Capital LLC (Filed With SEC on October 22, 2019)

Promissory Note, dated October 1, 2019, between Napo Pharmaceuticals, Inc. and Michael Tempesta (Filed With SEC on October 7, 2019)

License Termination and Settlement Agreement, dated October 1, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Michael Tempesta (Filed With SEC on October 7, 2019)

Warrant Exercise Agreement, dated October 2, 2019, between Jaguar Health, Inc. and the purchaser named therein (Filed With SEC on October 3, 2019)

Amendment No. 1 to Registration Rights Agreement, dated May 30, 2019, by and between Jaguar Health, Inc. and Sagard Capital Partners, L.P (Filed With SEC on September 27, 2019)

First Amendment to Landlord Letter of Credit & Warrant Issuance Agreement, dated September 16, 2019, by and between Jaguar Health, Inc. and Pacific Capital Management, LLC (Filed With SEC on September 20, 2019)

Promotion Letter, dated September 6, 2019 (Filed With SEC on September 9, 2019)

Form of Exchange Agreement, between Jaguar Health, Inc. and Chicago Venture Partners, L.P (Filed With SEC on August 14, 2019)

Form of Series 1 Warrant (Filed With SEC on July 23, 2019)

Form of Series 2 Warrant (Filed With SEC on July 23, 2019)

Form of Series 1 Warrant to purchase shares of common stock (Filed With SEC on July 18, 2019)

Form of Underwriting Agreement (Filed With SEC on July 18, 2019)

Form of Leak-out Agreement (Filed With SEC on July 18, 2019)

Form of Series 2 Warrant to purchase shares of common stock (Filed With SEC on July 18, 2019)

Form of Series 2 Warrant to purchase shares of common stock (Filed With SEC on July 15, 2019)

Form of Underwriting Agreement (Filed With SEC on July 15, 2019)

Form of Series 1 Warrant to purchase shares of common stock (Filed With SEC on July 15, 2019)

Form of Warrant Agency Agreement between the Company and American Stock Transfer & Trust Company, LLC (Filed With SEC on July 15, 2019)

Form of Amendment Agreement (Filed With SEC on July 5, 2019)

Specimen Common Stock Certificate of Jaguar Health, Inc (Filed With SEC on June 6, 2019)

Security Agreement, dated May 28, 2019, between Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P (Filed With SEC on June 3, 2019)

Security Agreement, dated May 28, 2019, between Jaguar Health, Inc. and Chicago Venture Partners, L.P (Filed With SEC on June 3, 2019)

Exchange Agreement, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P (Filed With SEC on June 3, 2019)

Guaranty and Suretyship Agreement, dated May 28, 2019, made by Jaguar Health, Inc (Filed With SEC on June 3, 2019)

Secured Promissory Note, dated May 28, 2019, by and among Jaguar Health, Inc., Napo Pharmaceuticals, Inc. and Chicago Venture Partners, L.P (Filed With SEC on June 3, 2019)

Letter of Credit Cancellation & Warrant Issuance Agreement, dated March 29, 2019, by and between Jaguar Health, Inc. and the letter of credit beneficiary named therein (Filed With SEC on April 4, 2019)

Form of LOC Common Stock Warrant (Filed With SEC on April 4, 2019)

Common Stock Purchase Agreement, dated April 1, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on April 1, 2019)

Form of Placement Agent Warrant (Filed With SEC on March 26, 2019)

Securities Purchase Agreement, dated March 24, 2019, by and between Jaguar Health, Inc. and the Investor (Filed With SEC on March 25, 2019)

Placement Agency Agreement, dated March 24, 2019, by and between Jaguar Health, Inc. and Ladenburg Thalmann & Co. Inc (Filed With SEC on March 25, 2019)

Form of Registration Rights Agreement (Filed With SEC on March 22, 2019)

Form of Securities Purchase Agreement (Filed With SEC on March 22, 2019)

Form of Common Stock Warrant (Filed With SEC on March 22, 2019)

Form of 125% Coverage Promissory Note (Filed With SEC on March 22, 2019)

Form of 75% Coverage Promissory Note (Filed With SEC on March 22, 2019)

Common Stock Purchase Agreement, dated January 7, 2019, by and between Jaguar Health, Inc. and Oasis Capital, LLC (Filed With SEC on January 8, 2019)

Jaguar Health, Inc. (106)